Depuy Synthes company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

depuysynthes.com

Founded Year

1895

Stage

Acquired | Acquired

Valuation

$0000 

About Depuy Synthes

Depuy Synthes offers a portfolio of orthopedic and neuro products and services for joint reconstruction, trauma, spine, sports medicine, neuro, craniomaxillofacial, power tools and biomaterials.Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands.

Depuy Synthes Headquarter Location

700 Orthopaedic Drive

Warsaw, Indiana, 46581,

United States

(800) 473-3789

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Depuy Synthes

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Depuy Synthes in 1 CB Insights research brief, most recently on Dec 20, 2019.

Expert Collections containing Depuy Synthes

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Depuy Synthes is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,383 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Depuy Synthes Patents

Depuy Synthes has filed 3309 patents.

The 3 most popular patent topics include:

  • Orthopedic surgical procedures
  • Implants (medicine)
  • Skeletal system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/27/2019

5/24/2022

Neurosurgery, Vascular diseases, Interventional radiology, Medical equipment, Cerebrovascular diseases

Grant

Application Date

3/27/2019

Grant Date

5/24/2022

Title

Related Topics

Neurosurgery, Vascular diseases, Interventional radiology, Medical equipment, Cerebrovascular diseases

Status

Grant

Latest Depuy Synthes News

11:08 EDT AANA Announces a Biannual Course Series for Underrepresented Medical Students

May 23, 2022

News provided by Share this article Share this article "The Future Scope: Introduction to Orthopaedics and Arthroscopy" course series will be co-developed and co-hosted by DePuy Synthes ROSEMONT, Ill., May 23, 2022 /PRNewswire/ -- Furthering the priority to promote diversity and inclusion within the orthopaedic community, the Arthroscopy Association of North America (AANA) announced that it will co-develop and co-host a biannual course series titled "The Future Scope: Introduction to Orthopaedics and Arthroscopy" with DePuy Synthes*, The Orthopaedics Company of Johnson & Johnson. The course series is truly the first of its kind and comes with a generational impact that aims to reach minorities in the field while addressing gender and racial disparities head-on. The program will launch in October and November 2022. The representation of minorities, including females, in orthopaedics compared to other medical specialties is staggeringly low, making introductory courses like this one essential. According to the Association of American Medical College's 2020 Physician Specialty Data Report, only 5.8% of all practicing Orthopaedic Surgeons in the United States are female – the lowest representation of women in all medical specialties. Additionally, while those who are underrepresented in medicine account for nearly 50.2% of all medical school students, just half of that number (25.6%) pursue an orthopaedic residency. The data clearly demands change, and AANA is committed to taking measures that recognize women and minorities in the field. To truly make a difference and execute this change, these medical students must be met early in their education for encouragement and mentoring, which is where the course series comes into play. This biannual course series for underrepresented medical students aims to address gender and racial disparities head-on. The course series, titled "Future Scope: Introduction to Orthopaedics and Arthroscopy," aims to introduce underrepresented medical students to the fundamentals of orthopaedic practice, professional opportunities within the field and insights into an orthopaedic career. The agenda for Future Scope is robust and includes lecture topics that serve as a brief overview while also introducing more trending topics such as biologics and rehabilitation. Additionally, Future Scope will include an esteemed faculty made up of seasoned surgeons who are considered "legends" in arthroscopy, sports medicine and orthopaedics. "Seeing the Future Scope course series through from concept to reality is something that I could only hope to end my presidential term on," says Mark H. Getelman, M.D., AANA's immediate past president, who concluded his presidency for the organization just today. "One of my presidential commitments was to ensure AANA's ability to be at the forefront of improving diversity and inclusion within orthopaedics, and the Future Scope course series helps AANA do just that. Partnering with DePuy Synthes will help attract medical students on a national level while supporting our ability to show them first-hand how rewarding a career in orthopaedics can be." DePuy Synthes' commitment involves a sponsorship of the course series from 2022-2024. The first course will take place October 1, 2022, at the MERCI Medical Lab in Park Ridge, Illinois, a premiere bioskills laboratory with over 24,000 square feet dedicated to hands-on learning, followed by a second course taking place November 5, 2022, at the Johnson & Johnson Institute in Raynham, Massachusetts. AANA is an international professional organization of more than 6,000 Orthopedic Surgeons and other medical professionals who are committed to advancing the field of minimally invasive orthopedic surgery to improve patient outcomes through education, research and advancement. * DePuy Synthes represents the products and services of DePuy Synthes Sales, Inc. and its affiliates. Media Contact:

  • When was Depuy Synthes founded?

    Depuy Synthes was founded in 1895.

  • Where is Depuy Synthes's headquarters?

    Depuy Synthes's headquarters is located at 700 Orthopaedic Drive, Warsaw.

  • What is Depuy Synthes's latest funding round?

    Depuy Synthes's latest funding round is Acquired.

  • Who are the investors of Depuy Synthes?

    Investors of Depuy Synthes include Johnson & Johnson.

  • Who are Depuy Synthes's competitors?

    Competitors of Depuy Synthes include Arthrex and 7 more.

You May Also Like

I
Inovedis

Inovedis is developing SINEFIX, a surgical technique and implant system for shoulder injuries that is based on a PEEK implant.

Nela Biodynamics Logo
Nela Biodynamics

Nela Biodynamics offers a novel modular system for intramedullary implants with a wide range of applications.

P
Precise Light Surgical

Precise Light Surgical is a medical device company focused on endoscopic surgery. The company's Flash Vaporization technology provides precision and control for the removal of delicate tissues to improve patient outcomes and reduce surgical risk and downtime while lowering treatment costs.

H
HARTMANN

The HARTMANN Group is a manufacturer of medical and hygiene products with a focus on wound treatment (eg wound dressings, negative pressure wound therapy, fixation bandages, plasters), incontinence care (eg disposable incontinence briefs and inserts as well as skincare products for incontinence) and infection control ( eg surgical complete sets, surgical clothing, surgical disposable instruments and disinfectants). The portfolio is supplemented by products for compression therapy, first aid and care and beauty products.

C
Ceretrieve

Ceretrieve designs and develops neurothrombectomy system with integrated embolic protection for ischemic stroke endovascular treatment. The company provides physicians easy-to-use devices to prevent distal embolization during thrombectomy procedures for better treatment efficiency and offers patients improved clinical outcomes. It is based in Misgav, Israel.

n
nView medical

nView medical develops imaging technology — bringing AI solutions for image creation, image processing, and image visualization to surgery and interventional radiology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.